Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Catherine Newsom"'
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164005 (2016)
This study assessed the validity of the Indicator of Bereavement Adaptation Cruse Scotland (IBACS). Designed for use in clinical and non-clinical settings, the IBACS measures severity of grief symptoms and risk of developing complications.N = 196 (44
Externí odkaz:
https://doaj.org/article/9ae83c5191194839b4f110e2e80d519b
Autor:
Clive S. Zent, Paul M. Barr, Michelle C. Janelsins, Philip J. Meacham, AnnaLynn M. Williams, Megan M Feldman, Hugo E Valencia, Nealansh Gupta, Catherine Newsom-Stewart, Andrea Baran
Publikováno v:
Leukemialymphoma. 59(3)
We studied the risk of infections in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL). Major infections were defined as requiring hospital admission or intravenous antimicrobial treatment. Incidence rate (IR) ratios (IRR) w
Autor:
Robert A Kurt, Chenyu Zhang, Jennifer Schwartz, Amanda Lauricella, Matthew Adusei, Matthew DeBenedetto, Catherine Newsom-Stewart
Publikováno v:
The Journal of Immunology. 202:135.9-135.9
Most of what we know about tumor associated macrophages (TAM) and tumor associated neutrophils (TAN) comes from analysis of these cells isolated from solid tumors, or the periphery of humans or mice with solid tumors. These studies have largely led t
Publikováno v:
Bereavement Care. 30:16-20
All too often it is assumed that the differing priorities, values and ethics of practitioners and researchers are irreconcilable. This article describes the long, sometimes difficult and ultimately fruitful process of setting up an evaluation of the
Autor:
Nealansh Gupta, AnnaLynn M. Williams, Philip J. Meacham, Megan M. Herr, Clive S. Zent, Catherine Newsom, Paul M. Barr, Michelle C. Janelsins, Andrea Baran, Hugo Valencia
Publikováno v:
Blood. 128:3203-3203
Introduction: Infection is a major source of morbidity and mortality in CLL. Improved treatment efficacy and decreased immune toxicity of treatment could have altered the spectrum and consequences of infections in patients with CLL. A better understa